The Wyss Center for Bio and Neuroengineering released a whitepaper revealing the first neural signals recorded by the Ability system. Ability is a wireless, implantable medical device known as a brain-computer interface (BCI) system. The Wyss Center team is developing the system with academic and clinical collaborators along with industrial technology partners. The aim for […]
Research & Development
GlucoTrack to begin R&D for new long-term CGM
GlucoTrack (Nasdaq:GCTK) announced that it plans to expand its product pipeline with an R&D program for a long-term continuous glucose monitor (CGM). Rutherford, New Jersey-based GlucoTrack said it recently required related IP. It now intends to develop a long-term, implantable glucose management platform for the type 1 diabetes market. Get the full story at our […]
This robotic capsule could deliver large-protein drugs like insulin
Researchers at the Massachusetts Institute of Technology (MIT) developed a new drug capsule with a robotic cap for improved drug delivery. Large-protein drugs generally can’t pass through the mucus barrier that lines the digestive tract. Insulin and most other “biologic drugs” with proteins or nucleic acids thus must be injected or administered in a hospital, […]
OraSure Technologies receives $8.6M contract to develop next-gen Ebola test
OraSure Technologies (Nasdaq:OSUR) announced today that received a government contract to develop a second-generation Ebola diagnostic. The Biomedical Advanced Research and Development Authority (BARDA) issued the company the $8.6 million contract. Bethlehem, Pennsylvania-based OraSure is to develop the test on its OraQuick testing platform. Its aim is to improve sensitivity, increase shelf life, introduce new […]
BD, CerTest launch monkeypox diagnostic for lab research in U.S.
BD (NYSE:BDX) and CerTest Biotec announced today that they made their monkeypox virus assay commercially available for global research. The companies made the diagnostic available outside of the U.S. for use in research applications by laboratories in July. The molecular polymerase chain reaction (PCR) assay is now available globally for research applications only. Franklin Lakes, New Jersey-based BD […]
Vaxxas receives more than $5 million grant for vaccine delivery patch
Vaxxas announced today the Australian government is granting it nearly $5.5 million for the manufacturing of its vaccine delivery device. Cambridge, Massachusetts-based Vaxxas picked up AU$8.2 million ($5.48 million). The second-round grant represents part of the Australian government’s Modern Manufacturing Initiative (MMI). Funding supports the manufacturing scale-up of Vaxxas’ device for applying vaccines to the […]
GE Healthcare, Wayra partner with startups to improve digital health across EMEA
GE Healthcare (NYSE:GE) and Wayra today announced a collaboration to name seven medtech startups to the Edison Accelerator program. The seven startups represent the second cohort of the Edison Accelerator in Europe, the Middle East and Africa (EMEA). The accelerator is a startup and scale-up program designed by GE Healthcare in partnership with UK-based Wayra. […]
Titan Medical, Medtronic strike development deal on surgical robots
Titan Medical (TSX:TMD;OTC:TITFX) today announced the signing of a new agreement with medtech giant Medtronic (NYSE:MDT). The definitive agreement builds upon a development and license deal agreed in June 2020. Titan achieved all three milestones laid out in the agreement, including raising $18 million in capital in October 2020. It also received a $10 million payment for the second […]
Accuray partners with Switzerland innovation hub
Accuray (Nasdaq:ARAY) announced that it partnered with the Genolier Innovation Hub to establish a new approach to improving patient care. Genolier, a subsidiary of Aevis Victoria, will unite companies from medtech, pharma and biosciences, as well as physicians and scientists. The goal is to bring medical and technological advances to patients faster. Plans call for […]
BD, Labcorp collaborate on flow cytometry-based diagnostics
BD (NYSE:BDX) announced today that it entered into a collaboration with Labcorp (NYSE:LH) to develop diagnostics. The collaboration aims to create the framework to develop, manufacture, market and commercialize flow cytometry-based companion diagnostics (CDx) intended to match patients with life-changing treatments for cancer and other diseases. Under the agreement, BD and Labcorp Drug Development will […]
ReCor Medical, Otsuka say renal denervation system met primary endpoint in U.S. study
ReCor Medical and Otsuka Medical Devices today announced positive results from a trial of its renal denervation system for hypertension. The Radiance II U.S. FDA investigational device exemption (IDE) pivotal trial evaluating the Paradise ultrasound renal denervation (uRDN) system as a treatment for hypertension met its primary efficacy endpoint, demonstrating a statistically significant reduction in […]